SEC Form 4 · accession 0001140361-17-040851
MAGELLAN HEALTH INC · MGLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel N Gregoire
Officer — General Counsel and Secretary
Period of report
Nov 1, 2017
Accepted (ET)
Nov 2, 2017 · 9:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000019411
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Common Stock, $ 0.01 par value | Nov 1, 2017 | X | 9,369 | $63.95 | A | 22,826 | D | |
| Ordinary Common Stock, $ 0.01 par valueF2 | Nov 1, 2017 | S | 9,369 | $89.2039 | D | 13,457 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F4,F3 | $63.95 | Nov 1, 2017 | X | 9,369 | D | — | Mar 5, 2025 | Common Stock | 9,369 | 15,771 | D |
Explanation of responses
- F1This transaction was effectuated pursuant to a Rule 10b5-1 Plan.
- F2The number of securities reported represents an aggregate number of shares sold in multiple market transactions over a range of sale prices, between $89.00 and $89.55 per share, inclusive. The price reported represents the weighted average price per share. The Reporting Person undertakes to provide the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.
- F3Of the 37,615 stock options granted, 3,233 are currently vested and exercisable. The remainder of 12,538 options shall vest on March 4, 2018
- F4Not applicable.